GLUE Operating Cash Flow (Statement)
Monte Rosa Therapeutics Inc · Operating Cash Flow (Statement)
GLUE Operating Cash Flow (Statement)
Latest reported-$44.11Mperiod ending
GLUE Quarterly Cash from Operations (-$3.38M → -$44.11M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
GLUE operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -44,114,000 | |
| -37,369,000 | |
| -43,014,000 | |
| 100,428,000 | |
| -34,720,000 | |
| -45,492,000 | |
| 128,922,000 | |
| -20,994,000 | |
| -27,767,000 | |
| -38,165,000 | |
| 29,634,000 | |
| -24,706,000 | |
| -25,324,000 | |
| -23,406,000 | |
| -23,961,000 | |
| -20,600,000 | |
| -20,501,000 | |
| -27,404,000 | |
| -14,172,000 | |
| -17,794,000 | |
| -13,582,000 | |
| -13,815,000 | |
| -8,574,000 | |
| -6,891,000 | |
| -4,212,000 | |
| -3,376,000 |